Laurence J. Marton's most recent trade in RenovoRx Inc was a trade of 9,720 Common Stock done . Disclosure was reported to the exchange on March 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| RenovoRx Inc | Laurence J. Marton | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Mar 2026 | 9,720 | 9,720 | - | - | Common Stock | |
| RenovoRx Inc | Laurence J. Marton | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Mar 2026 | 4,860 | 4,860 | - | - | Warrants | |
| RenovoRx Inc | Marton J. Laurence | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 47,640 | 47,640 | - | - | Stock Options (right to buy) | |
| RenovoRx Inc | Laurence J. Marton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 20,480 | 0 | - | - | Stock Option (right to buy) | |
| RenovoRx Inc | Laurence J. Marton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.15 per share. | 02 May 2025 | 20,480 | 66,164 | - | 0.2 | 3,072 | Common Stock |
| RenovoRx Inc | Laurence J. Marton | Director | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 08 Apr 2025 | 12,050 | 45,684 | - | 0.8 | 10,218 | Common Stock |
| RenovoRx Inc | Laurence J. Marton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 25,099 | 25,099 | - | - | Stock Options (right to buy) | |
| RenovoRx Inc | Marton Laurence J. | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 8,196 | 33,634 | - | - | Common Stock | |
| RenovoRx Inc | J. Marton Laurence | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 8,196 | 8,196 | - | - | Warrants | |
| RenovoRx Inc | Laurence J. Marton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 25,099 | 25,099 | - | - | Stock Option (right to buy) | |
| RenovoRx Inc | Laurence J. Marton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 4,582 | 4,582 | - | - | Stock Option (right to buy) |